Β. W. Low

978 total citations
22 papers, 796 citations indexed

About

Β. W. Low is a scholar working on Molecular Biology, Materials Chemistry and Spectroscopy. According to data from OpenAlex, Β. W. Low has authored 22 papers receiving a total of 796 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Materials Chemistry and 4 papers in Spectroscopy. Recurrent topics in Β. W. Low's work include Ion channel regulation and function (4 papers), Nicotinic Acetylcholine Receptors Study (4 papers) and Protein Structure and Dynamics (3 papers). Β. W. Low is often cited by papers focused on Ion channel regulation and function (4 papers), Nicotinic Acetylcholine Receptors Study (4 papers) and Protein Structure and Dynamics (3 papers). Β. W. Low collaborates with scholars based in United States, Sweden and Netherlands. Β. W. Low's co-authors include Jane S. Richardson, Peter W. R. Corfield, L. S. Rosen, Atsushi Sato, Joost P.H. Drenth, Catherine Wright, H. S. Preston, Wayne A. Hendrickson, J. L. Smith and F. M. Lovell and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Biochemical and Biophysical Research Communications.

In The Last Decade

Β. W. Low

22 papers receiving 732 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Β. W. Low United States 13 588 210 131 78 78 22 796
Vincent Pigiet United States 19 1.1k 1.9× 198 0.9× 229 1.7× 65 0.8× 46 0.6× 30 1.5k
C Griesinger Germany 6 938 1.6× 93 0.4× 183 1.4× 232 3.0× 59 0.8× 7 1.2k
S. Brunie France 20 1.4k 2.3× 677 3.2× 224 1.7× 50 0.6× 40 0.5× 33 1.7k
T.A. Holak Germany 18 720 1.2× 74 0.4× 127 1.0× 159 2.0× 62 0.8× 30 1.0k
Eiso AB Netherlands 18 991 1.7× 191 0.9× 205 1.6× 167 2.1× 30 0.4× 31 1.3k
Christoph Weber Switzerland 13 881 1.5× 75 0.4× 170 1.3× 181 2.3× 107 1.4× 14 1.1k
L. K. Ramachandran United States 16 412 0.7× 67 0.3× 52 0.4× 105 1.3× 23 0.3× 39 738
Robert H. Fairclough United States 13 662 1.1× 69 0.3× 67 0.5× 45 0.6× 31 0.4× 38 954
Tadeusz Gulik‐Krzywicki France 16 648 1.1× 104 0.5× 77 0.6× 70 0.9× 33 0.4× 23 874
Larry J. Weissman United States 7 459 0.8× 52 0.2× 99 0.8× 47 0.6× 26 0.3× 7 666

Countries citing papers authored by Β. W. Low

Since Specialization
Citations

This map shows the geographic impact of Β. W. Low's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Β. W. Low with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Β. W. Low more than expected).

Fields of papers citing papers by Β. W. Low

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Β. W. Low. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Β. W. Low. The network helps show where Β. W. Low may publish in the future.

Co-authorship network of co-authors of Β. W. Low

This figure shows the co-authorship network connecting the top 25 collaborators of Β. W. Low. A scholar is included among the top collaborators of Β. W. Low based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Β. W. Low. Β. W. Low is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grätz, Lukas, Jan Voss, Β. W. Low, et al.. (2024). A Putative Frizzled 7-Targeting Compound Acts as a Firefly Luciferase Inhibitor. Journal of Medicinal Chemistry. 67(24). 22332–22341. 2 indexed citations
2.
Corfield, Peter W. R., et al.. (1989). The Crystal Structure of Erabutoxin a at 2.0-Å Resolution. Journal of Biological Chemistry. 264(16). 9239–9242. 34 indexed citations
3.
Corfield, Peter W. R., et al.. (1989). The crystal structure of erabutoxin a at 2.0-A resolution.. PubMed. 264(16). 9239–42. 40 indexed citations
4.
Radding, Wilson, et al.. (1988). α‐Toxin binding to acetylcholine receptor α179–191 peptides: Intrinsic fluorescence studies. FEBS Letters. 231(1). 212–216. 21 indexed citations
5.
Smith, J. L., Peter W. R. Corfield, Wayne A. Hendrickson, & Β. W. Low. (1988). Refinement at 1.4 Å resolution of a model of erabutoxin b: treatment of ordered solvent and discrete disorder. Acta Crystallographica Section A Foundations of Crystallography. 44(3). 357–368. 90 indexed citations
6.
Drenth, Joost P.H., Β. W. Low, Jane S. Richardson, & Catherine Wright. (1980). The toxin-agglutinin fold. A new group of small protein structures organized around a four-disulfide core.. Journal of Biological Chemistry. 255(7). 2652–2655. 142 indexed citations
7.
Lundblad, Arne, Sigfrid Svensson, Β. W. Low, Lisbeth Messeter, & B. Cedergren. (1980). Release of Oligosaccharides from Human Erythrocyte Membranes of Different Blood-Group-P Phenotypes by Trifluoroacetolysis. European Journal of Biochemistry. 104(2). 323–330. 8 indexed citations
8.
Sato, Atsushi, et al.. (1979). Molecular conformation of erabutoxin b; Atomic coordinates at 2.5 Å resolution. Biochemical and Biophysical Research Communications. 88(3). 950–959. 77 indexed citations
9.
Low, Β. W., et al.. (1976). Three dimensional structure of erabutoxin b neurotoxic protein: inhibitor of acetylcholine receptor.. Proceedings of the National Academy of Sciences. 73(9). 2991–2994. 210 indexed citations
10.
Low, Β. W., et al.. (1975). The crystal structure of S-benzyl-L-cysteinyl-L-prolyl-L-leucylglycinamide and its selenium analog. Acta Crystallographica Section B. 31(3). 713–725. 15 indexed citations
11.
VEEN, J. M. VAN DER & Β. W. Low. (1972). The crystal structures of glycyl-L-phenylalanine p-toluenesulfonate and glycyl-L-phenylalanine p-bromobenzenesulfonate. Acta Crystallographica Section B. 28(12). 3548–3559. 5 indexed citations
12.
Low, Β. W., et al.. (1970). Studies of insulin crystals at low temperatures. Effects on lattice dimensions, temperature parameters and structure. Acta Crystallographica Section B. 26(11). 1756–1760. 2 indexed citations
13.
Magdoff-Fairchild, Beatrice, F. M. Lovell, & Β. W. Low. (1969). An X-ray Crystallographic Study of Ceruloplasmin. Journal of Biological Chemistry. 244(13). 3497–3499. 47 indexed citations
14.
Low, Β. W., et al.. (1968). Prediction of alpha-helical regions in proteins of known sequence.. Proceedings of the National Academy of Sciences. 60(4). 1519–1526. 19 indexed citations
15.
Low, Β. W., et al.. (1966). Preliminary X-ray crystallographic data for methyl 3-O-(1-carboxyethyl) shikimate δ-lactone. Acta Crystallographica. 20(6). 917–917. 2 indexed citations
16.
Low, Β. W., et al.. (1965). Insulin: preliminary X-ray studies of chloride crystals and a crystalline derivative. Acta Crystallographica. 19(4). 686–686. 4 indexed citations
17.
Einstein, J. R. & Β. W. Low. (1962). Insulin. Some shrinkage stages of sulfate and citrate crystals. Acta Crystallographica. 15(1). 32–34. 14 indexed citations
18.
Shoemaker, C. B., J. R. Einstein, & Β. W. Low. (1961). The three-dimensional Patterson function for insulin sulfate type A crystals. Acta Crystallographica. 14(5). 459–467. 3 indexed citations
19.
Low, Β. W., et al.. (1961). Insulin: preliminary X-ray studies of citrate crystals. Acta Crystallographica. 14(1). 82–82. 8 indexed citations
20.
Low, Β. W. & C. B. Shoemaker. (1959). Insulin: preliminary X-ray studies of two types of sulphate crystals. Acta Crystallographica. 12(11). 893–896. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026